Association of amyloid P component with complement proteins in neurologically diseased brain tissue

[1]  G. Plant,et al.  Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. , 1990, Brain : a journal of neurology.

[2]  P. Mcgeer,et al.  Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d , 1990, Neuroscience Letters.

[3]  P. Mcgeer,et al.  Immune System Response in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  J. Tebo,et al.  Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component (SAP) to macrophages. , 1988, Cellular immunology.

[5]  S. V. van Duinen,et al.  Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[6]  M. Black.  Amyloidosis and Amyloid P Component , 1988 .

[7]  S. Wright,et al.  Fibronectin and serum amyloid P component stimulate C3b- and C3bi- mediated phagocytosis in cultured human monocytes , 1983, The Journal of experimental medicine.

[8]  A. Feinstein,et al.  BIOLOGY OF SERUM AMYLOID P COMPONENT * , 1982, Annals of the New York Academy of Sciences.

[9]  A. Petrie,et al.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. , 1978, Clinical and experimental immunology.

[10]  H. Gewurz,et al.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Hockfield,et al.  In situ demonstration of mature oligodendrocytes and their processes: An immunocytochemical study with a new monoclonal antibody, Rip , 1989, Glia.